Overview
- A peer‑reviewed study published June 22, 2026 reports that common variants in the aquaporin‑4 (AQP4) gene change how sleep habits relate to early brain and cognitive signs of Alzheimer’s disease.
- The team genotyped 13 AQP4 variants and analyzed self‑reported sleep, longitudinal MRI, amyloid PET and cognition in 351 cognitively normal people with PET evidence of amyloid accumulation from the AIBL cohort.
- Results showed variant‑specific interactions: some AQP4 genotypes paired with short or disturbed sleep predicted faster gray‑matter loss, ventricular enlargement or worse cognitive trajectories, while other variants appeared protective under better sleep conditions.
- The biology points to the glymphatic system—AQP4 water channels on astrocytes that help clear waste such as amyloid‑beta during sleep—as a plausible mechanism linking sleep quality to amyloid removal and brain structure changes.
- The authors urge replication in larger and more diverse samples, use of objective sleep measures, and randomized genetics‑informed trials before any clinical testing or recommendations on AQP4 genetic screening are made.